TELA Bio, Inc. provided revenue guidance for the year 2024. For the year, the company expects Increased full year 2024 revenue guidance to $74.5 million to $76.5 million, representing 27% to 31% year-over-year growth.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.85 USD | -0.68% | -6.85% | -11.63% |
05-10 | Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating | MT |
05-09 | Earnings Flash (TELA) TELA BIO Posts Q1 Revenue $16.6M, vs. Street Est of $16.3M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.63% | 145M | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.57B | |
+2.64% | 49.95B | |
+6.58% | 43.84B | |
+4.91% | 41.71B | |
+21.98% | 31.59B | |
+14.45% | 25.3B | |
-5.81% | 23.94B |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- TELA Bio, Inc. Provides Revenue Guidance for the Year 2024